INO
Companies
NASDAQ
Inovio Pharmaceuticals, Inc.
Health Care
$1.95
+$0.12 (+6.56%)
Price Chart
Overview
About INO
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Market Cap
$248.5M
Volume
1.0M
Avg. Volume
1.1M
P/E Ratio
-0.5525606
Dividend Yield
0.00%
Employees
215.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.99
Moderate Correlation
Volatility
High (0.86)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, INO shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$248.5M
Volume1.0M
P/E Ratio-0.55
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 14, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025